Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis
暂无分享,去创建一个
A. Murphy | G. Yancopoulos | N. Gale | G. Thurston | K. Anderson | M. Dominguez | D. Valenzuela | I. Noguera-Troise | C. Daly | S. Davis | V. Hughes | L. Pan | M. Simmons | Virginia C. Hughes | Li Pan | Mary V. Simmons
[1] G. Yancopoulos,et al. F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses , 2007, Nature Biotechnology.
[2] C. Drake,et al. PTPs seize the spotlight from RTKs in vasculogenesis , 2006 .
[3] D. Vestweber,et al. Vascular endothelial cell–specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development , 2006 .
[4] Janet Rossant,et al. Endothelial cells and VEGF in vascular development , 2005, Nature.
[5] Christopher J Drake,et al. Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[6] Gavin Thurston,et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Tasuku Honjo,et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. , 2004, Genes & development.
[8] Janet Rossant,et al. Dosage-sensitive requirement for mouse Dll4 in artery development. , 2004, Genes & development.
[9] Yi Wei,et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). , 2004, Genes & development.
[10] Li Yuan,et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac , 2003, Development.
[11] A. F. Stewart,et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis , 2003, Nature Biotechnology.
[12] Paul A. Fleming,et al. A Mutant Receptor Tyrosine Phosphatase, CD148, Causes Defects in Vascular Development , 2003, Molecular and Cellular Biology.
[13] D. Shima,et al. VE‐PTP and VE‐cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts , 2002, The EMBO journal.
[14] P. Campochiaro,et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.
[15] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[16] K. Alitalo,et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. , 1998, Science.
[17] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[18] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[19] R. Jain,et al. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. , 1996, Microvascular research.
[20] C. Little,et al. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] Thomas N. Sato,et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.
[22] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[23] M. Gertsenstein,et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.
[24] Haruo,et al. Structural diversity and evolution of human receptor‐like protein tyrosine phosphatases. , 1990, The EMBO journal.